What is it about?
Use of protese inhibitors in patients with HIV is a cornerstone in treatment. The present study gives informationon use of Darunavir in a l'argento varietà of patients both nave and pre treated
Featured Image
Why is it important?
This study obsrved > 800 patients up to 7 years
Perspectives
Protese inhibitors can have a role in future treatment of HIV in particular Darunavir will remain as the Only PI. Having daily practice informationin both nave and pre treated patients can help physicians to make there choice in a more informe way
Doctor Roberta Termini
Read the Original
This page is a summary of: Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study, Drug Design Development and Therapy, May 2016, Dove Medical Press,
DOI: 10.2147/dddt.s104875.
You can read the full text:
Contributors
The following have contributed to this page
